Scotland has some of the best health service data in the world. Few other countries have information which combines high quality data, consistency, national coverage and the ability to link data to allow patient based analysis and follow up. The Information Services Division (ISD) is a division of National Services Scotland, part of NHS Scotland. ISD provides health information, health intelligence, statistical services and advice that support the NHS in progressing quality improvement in health and care and facilitates robust planning and decision making.
What's New in ISD?
Antimicrobials: No room for complacency despite solid progress
A report published today by Health Protection Scotland and Information Services Division on behalf of the Scottish Antimicrobial Prescribing Group (SAPG) shows that work by SAPG to improve the quality of antibiotic use is paying dividends. However, the report also stresses that there can be no let-up in the drive to further reduce unnecessary prescribing. In 2013 the use of systemic antibacterials in primary care (excluding dental) was 5.4% lower than in 2012 - the largest annual reduction since 2000. The total use of systemic antibacterials in hospitals showed a 1.6% increase from 2012. There has been a continued upward trend since 2009; however, the increase in the rate of prescribing observed in 2013 was lower than in previous years.
Professor Dilip Nathwani, Chair of SAPG said: "This recent report show clear progress, and the reductions in actual prescribing rates and increase trends of less total use and the use of key antibiotic in hospitals is also very encouraging. I'd like to express my thanks to Scottish healthcare professionals and the public for helping us to achieve these successes. However, there is no room for complacency here and we have a long way to go. We must continue to reduce unnecessary antimicrobial use in all healthcare settings if we are to preserve the effectiveness of this very important group of drugs. Furthermore, we need to remain vigilant of maintaining and improving the reductions we have achieved in C. difficile infections and keeping our resistance rates at low levels."
[27 January 2015]
Child & Adolescent Mental Health Benchmarking Release
Our Mental Health Benchmarking tools have been designed to support staff drive continuous improvement in the provision of mental health services in Scotland.
The latest CAMHS Benchmarking Toolkit and Dashboard (for data up to September 2014) contains information on the Child and Adolescent Mental Health Services (CAMHS) waiting times and workforce statistics.
[Updated 13 January 2015]
Welcome to myISD. This is a feature that allows you to personalise your homepage and keep all the parts of the website you use regularly in one easy to find place. You can sign up for the newsletters you like to see and set any preferences. You will need to fill in a simple form to register for myISD. That lets us see the features you use regularly so we can make the site better for you.
- Coronary heart disease (CHD), which includes heart attacks, is a leading cause of illness and death in Scotland.
- The number of new cases of CHD (incidence) has decreased over the past decade. The age and sex standardised incidence rate decreased by 30.4% between 2004/05 and 2013/14.
- There has been a steady downward trend in deaths from CHD in Scotland, UK and Europe over the last 10 years with the mortality rate in Scotland falling by 43.2%.
- The reduction in death rates for CHD over the decade 2004-2013 has been seen in both the most and least materially deprived communities. The percentage reduction in deaths in the most deprived category (40.7%) over the last 10 years is smaller than that in the least deprived category (46.4%). However, the absolute difference in the death rate between the most and least deprived areas has decreased over the last decade.
- For those admitted to hospital as an emergency with their first heart attack, the chances of surviving at least 30 days have improved over the last ten years from 85.1% to 91.8%.
- Cerebrovascular disease (CVD) develops as a result of problems with the blood vessels supplying the brain. The number of new cases of CVD in Scotland has decreased over the last decade. The incidence rate of CVD in Scotland was 328.9 per 100,000 population in 2004/05 compared to 257.4 per 100,000 in 2013/14, a decrease of 21.8%. Incidence rates for CVD are consistently higher in males than females.
- The decrease in mortality rates for stroke in men (43.1%) has been greater than for women (39.3%). For the last three years, the stroke mortality rate for women has been slightly higher than that for men.
- The percentage of people surviving 30 days or more following their first emergency admission to hospital with a stroke has improved slightly over the last 10 years from 80.8% in 2004/05 to 84.9% in 2013/14.
- Although the number of prescriptions for drugs to treat cardiovascular disease (all diseases of the circulation, including stroke) increased by 16.9% in the last 10 years, the overall costs of prescriptions dispensed for cardiovascular drugs fell in 2013/14 to £102.9 million, a reduction of 7.8% on the previous year. This is the lowest cost for these drugs over the last ten years (since 2004/05). Costs may continue to reduce as medicines become available in less expensive, non-branded (generic) form.
- In 2013, the use of antibacterials in primary care was lower than in 2012. This reduction was observed both in terms of antibiotic items (down 5.4%) and Defined Daily Doses (down 2.5%).
- In 2013 an increase of 1.6% was observed in the total use of antibacterials in hospitals compared to 2012. This continues the upward trend seen since 2009, however the rate of increase is less than it has been for previous years.
- A continued increase in the use of carbapenems in Scottish hospitals was observed. However, the increase from 2012 to 2013 was lower than that of previous years. Despite this rise resistance to carbapenems among Gram-negatives remains low, with 0.2% of K. pneumoniae and none of the E. coli isolates being resistant to meropenem.
- However, the epidemiological status of carbapenemase producers in Scotland recently changed from ‘sporadic’ to ‘regional spread’ following two incidents of local spread reported in 2014. An increase in meropenem resistance was also observed among Scottish E. coli urinary isolates (from 0% in 2012 to 0.03% in 2013)
- There was continued progress in 2013 toward reduction in the use of broad spectrum antibacterials associated with Clostridium difficile infection (CDI) in primary care with a 12.7% decrease
- There was a 4.5% increase in the use of co-amoxiclav in secondary care in 2013 as compared to 2012. This coincided with an increase in resistance to co-amoxiclav among E. coli bacteraemias from 18.4% in 2012 to 28.4% in 2013, above that reported in 2009-2011 (range: 23.4%-25.4%).
- The use of piperacillin-tazobactam has continued to rise, with a 7.4% increase in 2013 as compared 2012. The high resistance (8.6% in 2013) to piperacillin-tazobactam among E. coli bacteraemias is of concern due to its frequent clinical use.
- Almost 9 out of 10 people in Scotland are now registered with an NHS dentist, the highest reported rate (87%; over 4.6 million).
- Children are more likely to be registered than adults (92% compared with 85%).
- Registration has been increasing since 2007, as a result of several changes in the time after which registration lapses have been introduced.
- 74% of those registered with an NHS dentist in September 2014 had seen their dentist within the last two years.
- Children are more likely than adults to have seen the dentist within the last two years (86% compared with 71%).
- Two NHS Boards (NHS Lanarkshire and NHS Shetland) met the H9 HEAT target of 60% of children aged three years old and those aged four years old receiving two or more FV treatments in 2013/14 for all quintiles of deprivation.
- There has been an increase in the number of children receiving FV treatment across Scotland, and within each of the NHS Boards.
- The data shows a clear deprivation gradient within Scotland and in the majority of the NHS Boards, with children in the most deprived quintiles most likely to receive FV.
- Nationally the total number of 3 year old children receiving two or more FV treatments has increased from 12,192 in 2012/13 to 19,320 in 2013/14.
- Nationally the total number of 4 year old children receiving two or more FV treatments has increased from 13,068 in 2012/13 to 21,235 in 2013/14.
The mapped expenditure across health and social care sectors for the financial year ending 31 March 2013 shows that:
- 50.5% (£2.33bn) of all expenditure (£4.61bn) on individuals aged 65 years and over was within a hospital setting; of which 61.7% (£1.44bn) was accounted for by an unplanned admission;
- 75.4% (£5.01bn) of all expenditure on individuals under 65 years was within health; of which 57.9% (£2.90bn) was spent within the hospital setting.
- 28.0% (£1.29bn) of all expenditure on individuals aged 65 years and over was within a social care setting; of which 50.3% (£0.65bn) was attributed to accommodation-based care; and
- 7.8% (£0.36bn) of all expenditure on individuals aged 65 years and over was accounted for by GP prescribing.
Update to Tobacco control profiles on the ScotPHO website, including some new indicators at National Local Authority and Health Board level. The tool includes spine charts, rank charts and time trends.